DC
PBH icon

Davenport & Co’s Prestige Consumer Healthcare PBH Stock Holding History

Davenport & Co’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
25,394
-660
-3% -$33.9K 0.01% 720
2026
Q1 		$1.54M Buy
26,054
+4,585
+21% +$297K 0.01% 590
2025
Q4 		$1.32M Sell
21,469
-1,142
-5% -$69.9K 0.01% 630
2025
Q3 		$1.41M Buy
22,611
+1,883
+9% +$131K 0.01% 605
2025
Q2 		$1.66M Buy
20,728
+5,264
+34% +$440K 0.01% 558
2025
Q1 		$1.33M Sell
15,464
-60
-0.4% -$4.92K 0.01% 588
2024
Q4 		$1.21M Buy
+15,524
New +$1.21M 0.01% 604

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Davenport & Co's PBH Position: Q2 2026 in Review

Davenport & Co reduced its Prestige Consumer Healthcare (PBH) stake by 2.5% in Q2 2026, selling an estimated $33.9K and leaving 25,394 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #720.

Davenport & Co first reported a position in PBH in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.66M in Q2 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Davenport & Co held 25,394 shares of Prestige Consumer Healthcare worth $1.2M as of Q2 2026.
  • Davenport & Co sold 660 Prestige Consumer Healthcare shares in Q2 2026, an estimated $33.9K.
  • Prestige Consumer Healthcare made up 0.01% of Davenport & Co's portfolio in Q2 2026, its #720 holding.
  • Davenport & Co first reported a position in Prestige Consumer Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Davenport & Co's Prestige Consumer Healthcare position peaked at $1.66M in Q2 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.